Renal Cell Cancer Update

PARP Inhibition in Pancreatic Cancer with Dr Michael Pishvaian

Informações:

Sinopse

Dr Michael Pishvaian from the Johns Hopkins University School of Medicine in Washington, DC, discusses recent therapeutic advances in pancreatic cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPancreasPARP21).